Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Oragenics, Inc. (OGEN : AMEX)

• Company Description    Oragenics Inc is a biotechnology company focused on the development and licensure of innovative products and technologies for improving human health. Number of Employees: 6

• Price / Volume Information    Yesterday's Closing Price: $0.42 Daily Weekly Monthly 20 Day Moving Average: 23,188 shares Shares Outstanding: 4.51 (millions) Market Capitalization: $1.88 (millions) Beta: 1.26 52 Week High: $1.34 52 Week Low: $0.40 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -17.08% -16.20% 12 Week -14.91% -16.99% Year To Date -46.74% -53.77%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 9015 TOWN CENTER PARKWAY SUITE 143 - LAKEWOOD RANCH,FL 34202 USA ph: 813-286-7900 fax: 813-286-7904 ir@oragenics.com http://www.oragenics.com

• General Corporate Information    Officers Janet Huffman - Chief Executive Officer & Chief Financial Officer Robert C. Koski - Director Charles L. Pope - Director Frederick W. Telling - Director Alan W. Dunton - Director Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 684023609 SIC: 2834 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/26 Next Expected EPS Date: 11/06/26 Share - Related Items Shares Outstanding: 4.51 Most Recent Split Date: 6.00 (0.03:1) Beta: 1.26 Market Capitalization: $1.88 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/06/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.51 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: 81.61% vs. Previous Quarter: -11.76% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 09/30/26 - - 06/30/26 - -144.22 03/31/26 - -177.32 ROA 09/30/26 - - 06/30/26 - -112.79 03/31/26 - -121.29 Current Ratio 09/30/26 - - 06/30/26 - 3.01 03/31/26 - 5.73 Quick Ratio 09/30/26 - - 06/30/26 - 3.01 03/31/26 - 5.73 Operating Margin 09/30/26 - - 06/30/26 - - 03/31/26 - - Net Margin 09/30/26 - - 06/30/26 - - 03/31/26 - - Pre-Tax Margin 09/30/26 - - 06/30/26 - - 03/31/26 - - Book Value 09/30/26 - - 06/30/26 - 0.81 03/31/26 - 1.43 Inventory Turnover 09/30/26 - - 06/30/26 - - 03/31/26 - - Debt-to-Equity 09/30/26 - - 06/30/26 - 0.00 03/31/26 - 0.00 Debt-to-Capital 09/30/26 - - 06/30/26 - 0.00 03/31/26 - 0.00

Powered by Zacks Investment Research ©